NCT02739282View on ClinicalTrials.gov

Therapeutic Drug Monitoring of New Generation Antiepileptic Drugs

NACompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

January 8, 2019

Study Completion Date

January 8, 2019

Conditions
Epilepsy
Interventions
OTHER

Systematic therapeutic drug monitoring

Blood samples with antiepileptic drug level measurement

Trial Locations (1)

1011

CHUV, Lausanne

All Listed Sponsors
lead

Dr Jan Novy

OTHER

NCT02739282 - Therapeutic Drug Monitoring of New Generation Antiepileptic Drugs | Biotech Hunter | Biotech Hunter